ScoreWhy is Sino Biological Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -16.93% and Operating profit at -52.02% over the last 5 years
2
The company has declared Negative results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 199.18 MM
- DEBT-EQUITY RATIO (HY) Highest at -60.82 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 3.15 times
3
With ROE of 2.22%, it has a very attractive valuation with a 1.54 Price to Book Value
- Over the past year, while the stock has generated a return of 7.17%, its profits have fallen by -33.2%
- At the current price, the company has a high dividend yield of 3.3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sino Biological Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sino Biological Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sino Biological Inc.
7.17%
0.33
33.41%
China Shanghai Composite
16.67%
1.14
14.96%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-16.93%
EBIT Growth (5y)
-52.02%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.11
Tax Ratio
9.18%
Dividend Payout Ratio
104.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
129.55%
ROE (avg)
16.65%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
70
Industry P/E
Price to Book Value
1.54
EV to EBIT
147.43
EV to EBITDA
37.40
EV to Capital Employed
2.53
EV to Sales
8.31
PEG Ratio
NA
Dividend Yield
3.31%
ROCE (Latest)
1.72%
ROE (Latest)
2.22%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET PROFIT(HY)
At CNY 83.45 MM has Grown at 46.88%
RAW MATERIAL COST(Y)
Fallen by -12.18% (YoY
NET SALES(Q)
Highest at CNY 186.99 MM
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 199.18 MM
DEBT-EQUITY RATIO
(HY)
Highest at -60.82 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.15 times
Here's what is working for Sino Biological Inc.
Net Profit
At CNY 83.45 MM has Grown at 46.88%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Sales
Highest at CNY 186.99 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -12.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sino Biological Inc.
Operating Cash Flow
Lowest at CNY 199.18 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -60.82 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 3.15 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
